Interleukin-1β, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis

Oral Microbiology and Immunology

Volumn 21, Issue 4, 2006, Pages 256-260

  Orozco, A ^a   Gemmell, E ^a   Bickel, M ^a   Seymour, G J ^b  

^a School of Dentistry   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cytokines; Gingival crevicular fluid; Gingivitis; Periodontitis

Indexed keywords

INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1; INTERLEUKIN 12; PROTEIN SUBUNIT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GINGIVITIS; HUMAN; PERIODONTITIS; PROTEIN BLOOD LEVEL; AGED; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-18; MALE; MIDDLE AGED; PERIODONTITIS; PROTEIN SUBUNITS; TH1 CELLS; TH2 CELLS;

EID: 33748355626     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2006.00292.x     Document Type: Article

References (38)

1. Abbas AK, Lichtman AH. Cellular and molecular immunology. Philadelphia, PA: JB Saunders, 2003.
2. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002: 80: 147-162.
3. Champaiboon C, Yongvanitchit K, Pichyangkul S, Mahanonda R. The immune modulation of B-cell responses by Porphyromonas gingivalis and interleukin-10. J Periodontol 2000: 71: 468-475.
4. Chapple CC, Srivastava M, Hunter N. Failure of macrophage activation in destructive periodontal disease. J Pathol 1998: 186: 281-286.
5. Delaleu N, Bickel M. Interleukin-1 beta and interleukin-18: regulation and activity in local inflammation. Periodontol 2000 2004: 35: 42-52.
6. Ellis SD, Tucci MA, Serio FG, Johnson RB. Factors for progression of periodontal diseases. J Oral Pathol Med 1998: 27: 101-105.
7. Fokkema SJ, Loos BG, de Slegte C et al. Increased release of IL-12p70 by monocytes after periodontal therapy. J Clin Periodontol 2003: 30: 1091-1096.
8. Fokkema SJ, Loos BG, Slegte C, van der Velden U. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol 2002: 127: 374-378.
9. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000: 71: 1535-1545.
10. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin- 12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998: 16: 495-521.
11. Gemmell E, Seymour GJ. Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 1998: 77: 16-26.
12. Holmlund A, Hanstrom L, Lerner UH. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. J Clin Periodontol 2004: 31: 475-482.
13. Honig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Increased interleukin-1 beta (IL-1 beta) concentration in gingival tissue from periodontitis patients. J Periodontal Res 1989: 24: 362-367.
14. Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1997: 32: 524-529.
15. Johnson RB, Serio FG. Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 2005: 76: 785-790.
16. Kashiwamura S, Ueda H, Okamura H. Roles of interleukin-18 in tissue destruction and compensatory reactions. J Immunother 2002: 25 (Suppl. 1): S4-S11.
17. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963: 21: 533-551.
18. Loesche W, Grossman N. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001: 14: 727-752.
19. Lotze MT, Tahara H, Okamura H. Interleukin-18 as a novel, distinct, and distant member of the interleukin-1 family promoting development of the adaptive immune response: the interleukin-18 issue of the Journal of Immunotherapy. J Immunother 2002: 25 (Suppl. 1): S1-S3.
20. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodontal Res 1990: 25: 156-163.
21. Murphy KM, Ouyang W, Farrar JD et al. Signaling and transcription in T helper development. Annu Rev Immunol 2000: 18: 451-494.
22. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001: 19: 423-474.
23. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998: 8: 275-283.
24. Ohshima M, Otsuka K, Suzuki K. Interleukin-1 beta stimulates collagenase production by cultured human periodontal ligament fibroblasts. J Periodontal Res 1994: 29: 421-429.
25. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998: 9: 248-266.
26. Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995: 378: 88-91.
27. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000: 117: 1162-1172.
28. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997: 14: 216-248.
29. Park AY, Scott P. IL-12: keeping cell-mediated immunity alive. Scand J Immunol 2001: 53: 529-532.
30. Schwartz Z, Goultschin J, Dean DD, Boyan BD. Mechanisms of alveolar bone destruction in periodontitis. Periodontol 2000 1997: 14: 158-172.
31. Seymour GJ, Gemmell E. Cytokines in periodontal disease: where to from here? Acta Odontol Scand 2001: 59: 167-173.
32. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000: 79: 1864-1869.
33. Silness J, Loee H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964: 22: 121-135.
34. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991: 18: 548-554.
35. Tsai IS, Tsai CC, Ho YP, Ho KY, Wu YM, Hung CC. Interleukin-12 and interleukin-16 in periodontal disease. Cytokine 2005: 31: 34-40.
36. Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K. Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol 1997: 12: 281-287.
37. Yun PL, Decarlo AA, Collyer C, Hunter N. Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun 2001: 69: 5650-5660.
38. Yun PL, DeCarlo AA, Collyer C, Hunter N. Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases. Infect Immun 2002: 70: 5695-5705.